LAMA and ICS/LABA drugs Flashcards
aclidinium brand
turdorza pressair
aclidinium (turdorza pressair) dosage form
400 mcg per inhalation
glycopyrrolate (seebri neohaler) dosage forms
DPI - 15.6 mcg capsule
Nebulization solution - 25 mcg/mL
glycopyrrolate brand
seebri neohaler
revefenacin brand
yupelri
revefenacin (yupelri) dosage form
nebulization solution
175 mcg (1 unit dose vial)
tiotropium brand
spiriva
tiotropium (spiriva) dosage forms
handihaler - 18 mcg capsule
respimat - 1.25 or 2.5 mcg/inhalation
umeclidinium brand
incruse ellipta
umeclidinium (incruse ellipta) dosage form
DPI
62.5 mcg/inhalation
aclidinium (turdorza pressair) dosing in adults
one inhalation bid
COPD only
glycopyrrolate (seebri neohaler) dosing in adults
DPI - one capsule bid
Nebulization Solution - one vial bid
COPD only
revenfenacin (yupelri) dosing in adults
one nebulization qd
COPD only
tiotropium (spiriva) dosing in adults
handihaler - contents of one capsule qd (COPD only)
respimat - two inhalations qd
umeclidinium (incruse ellipta) dosing in adults
one inhalation qd
COPD only
tiotropium (spiriva) dosing in 4-11 yos
only approved in over 6 yos
respimat - two inhalations qd
adverse effects of LAMAs
dry mouth
dizziness
blurred vision
upper respirator infections
paradoxical bronchospams
clincial pearls of LAMA
tiotropium has been approved for use in asthma as an add-on option for children under 12 yos
LAMAs
long acting antimuscarinics
block the bronchoconstrictor effects of acetylcholine on M3 and M2 receptors
LAMA drugs
aclidinium (turdorza pressair)
glycopyrrolate (seebri neohaler)
revenfenacin (yupelri)
tiotropium (spiriva)
umeclidinium (incruse ellipta)
ICS/LABA combo drugs
fluticasone/salmeterol (advair, AirDuo, AirDuo Digihaler)
budesonide/formoterol (symbicort)
mometasone/formoterol (dulera)
fluticasone/vilanterol (breo ellipta)
fluticasone/salmeterol brands
advair
airduo
airduo digihaler
budesonide/formoterol brand
symbicort
fluticasone salmeterol (advair) dosage forms
DPI - 100 mcg/50mcg, 250mcg/50mcg, and 500mcg/50mcg
HFA MDI - 45 mcg/21mcg, 114mcg/21mcg, and 230mcg/21mcg
fluticasone/salmeterol (AirDuo and AirDuo Digihaler) dosage form
respiclick (DPI)
55mcg/14 mcg
113mcg/14 mcg
232mcg/14 mcg
budesonide/formoterol (symbicort) dosage form
HFA MDI
80 mcg/4.5 mcg
160 mcg/4.5 mcg
fluticasone/salmeterol (advair) dosing in adults
DPI - one inhalation bid
HFA - two inhalations bid
fluticasone/salmeterol (advair) dosing in 5-11 yos
over 4 yos
DPI only
two inhalation bid of 100mcg/50mcg product
fluticasone/salmeterol (airduo, airduo digihaler) dosing in adults
one inhalation bid
budesonide/formoterol (symbicort) dosing in adults
two inhalations bid
budesonide/formoterol (symbicort) dosing in 5-11 yos
two inhalations bid
ICS/LABA combo adverse effects
individual product’s profile
clinical pearls of ICS/LABA combos
guidelines recommend combination LABA with ICS in asthma, as LABA should not be used as a monotherapy
combination products developed to create convenient packaging and assist with patient adherence
mometasone/formoterol brand
dulera
mometasone/formoterol (dulera) dosage form
MDI
100mcg/5mcg
200mcg/5mcg
fluticasone/vilanterol brand
breo ellipta
fluticasone/vilanterol (breo ellipta) dosage form
DPI
100 mcg/5 mcg
200 mcg/ 25 mcg
mometasone/formoterol (dulera) dosing in adults
two inhalations bid
fluticasone/vilanterol (breo ellipta) dosing in adults
one inhalation qd